Wang‐Xiang Xu
- Topics
- Liver physiology and pathology (10 papers)Liver Disease Diagnosis and Treatment (3 papers)Cancer, Hypoxia, and Metabolism (3 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Wang‐Xiang Xu
23 papers receiving 746 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 475
- Epidemiology 122
- Hepatology 111
- Cancer Research 111
- Surgery 87
Countries citing papers authored by Wang‐Xiang Xu
This map shows the geographic impact of Wang‐Xiang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang‐Xiang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang‐Xiang Xu more than expected).
Fields of papers citing papers by Wang‐Xiang Xu
This network shows the impact of papers produced by Wang‐Xiang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang‐Xiang Xu. The network helps show where Wang‐Xiang Xu may publish in the future.
Co-authorship network of co-authors of Wang‐Xiang Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Wang‐Xiang Xu. A scholar is included among the top collaborators of Wang‐Xiang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wang‐Xiang Xu. Wang‐Xiang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 49 | |
| 3 | 4 | |
| 4 | 29 | |
| 5 | 18 | |
| 6 | 4 | |
| 7 | 13 | |
| 8 | [Construction of a recombinant stable Ba/F3 cell strain containing Tpr-Met]. | 1 |
| 9 | 28 | |
| 10 | 275 | |
| 11 | 72 | |
| 12 | 9 | |
| 13 | 44 | |
| 14 | 53 | |
| 15 | 4 | |
| 16 | 27 | |
| 17 | 8 | |
| 18 | [Overexpression of EDAG-1 in NIH3T3 cells leads to malignant transformation]. | 9 |
| 19 | 70 | |
| 20 | 20 |
About Wang‐Xiang Xu
Wang‐Xiang Xu is a scholar working on Hepatology, Cancer Research and Molecular Biology, having authored 23 papers that have together received 755 indexed citations. Recurring topics across this work include Liver physiology and pathology (10 papers), Liver Disease Diagnosis and Treatment (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Hepatology (111 citations), Cancer Research (111 citations) and Molecular Biology (475 citations). Wang‐Xiang Xu has collaborated with scholars based in China and United States. Frequent co-authors include Xiaoming Yang, Yi‐Qun Zhan, Chang‐Yan Li, Chang‐Hui Ge, Miao Yu, Liujun Tang, Wei Li, Yanzhi Yuan, Hui Li and Qiongming Liu. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.